Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home
Share
Compartir

Publications: group A Streptococcus

2000 to Present:

  • Dooling KL, Crist MB, Nguyen DB, Bass J, Lorentzson L, Toews KA, Pondo T, Stone ND, Beall B, Van Beneden C. Investigation of a prolonged group a streptococcal outbreak among residents of a skilled nursing facility, Georgia, 2009-2012. Clin Infect Dis. 2013;57(11):1562-7.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2012 [1 page].
  • Fittipaldi N, Olsen RJ, Beres SB, Van Beneden C, Musser JM. Genomic analysis of emm59 group A Streptococcus invasive strains, United States. Emerg Infect Dis. 2012;18(4):650-52.
  • Olsen RJ, Laucirica DR, Watkins ME, Feske ML, Garcia-Bustillos JR,Vu C,Cantu C, Shelburne SA 3rd,Fittipaldi N. Kumaraswami M, Shea PR, Flores AR, Beres SB, Lovgren M, Tyrrell GJ, Efstratiou A, Low DE, Van Beneden C, Musser JM. Polymorphisms in Regulator of Protease B (RopB) Alter Disease Phenotype and Strain Virulence of Serotype M3 Group A Streptococcus. J Infect Dis. 2012; 205(11):1719-29.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2011 [1 page].
  • Deutscher M, Lewis M, Zell ER, Taylor THJr, Van Beneden C, Schrag S. Active Bacterial Core Surveillance Team. Incidence and severity of invasive Streptococcus pneumoniae, group A Streptococcus, and group B Streptococcus infections among pregnant and postpartum women. Clin Infect Dis. 2011; 53(2):114-23.
  • Angeles K, Nichols M, Bareta J, Baumbach J. Invasive Group A Streptococcal: New Mexico, 2004-2009. New Mexico Epidemiology. 2010;2010(9).
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2010.
  • Ahmad Y, Gertz RE, Jr., Li Z, Sakota V, Broyles LN, Van Beneden C, et al. Genetic relationships deduced from emm and multilocus sequence typing of invasive Streptococcus dysgalactiae subsp. equisimilis and S. canis recovered from isolates collected in the United States. J Clin Microbiol. 2009;47(7):2046-54.
  • Broyles LN, Van Beneden C, Beall B, Facklam R, Shewmaker PL, Malpiedi P, et al.  Population-based study of invasive disease caused by beta-hemolytic streptococci of groups other than A and B. Clin Infect Dis. 2009;48(6):706-12.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2009.
  • Lauth X, von Köckritz-Blickwede M, McNamara CW, Myskowski S, Zinkernagel AS, Beall B, et al. M1 protein allows group A Streptococcal survival in phagocyte extracellular traps through Cathelicidin inhibition. J Innate Immun. 2009; 1:202-14.
  • Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis. 2009;10:611-6.
  • Centers for Disease Control and Prevention. Group A streptococcal M protein gene database. Downloadable FTP databases; updated 12/18/08.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2008.
  • Rainbow J, Jewell B, Danilla RN, Boxrud D, Beall B, Van Beneden C, et al. Invasive Group A Streptococcal Disease in Nursing Homes, Minnesota, 1995-2006. Emerg Inf Dis. 2008; 14(5):772-77.
  • Woodbury RL, Klammer KA, Xiong Y, Bailiff T, Glennen A, Bartkus JM, et. al for the ABCs Team. Plasmid-Borne erm(T) from Invasive, Macrolide-Resistant Streptococcus pyogenes Strains. Antimicrob Agents Chemother. 2008;52(3):1140-3.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2007.
  • O’Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, et al for the Active Bacterial Core Surveillance Team. The Epidemiology of Invasive Group A Streptococcal Infection and Potential Vaccine Implications: United States, 2000-2004. Clin Infect Dis. 2007;45:853-61.
  • Thigpen MC, Richards CL, Lynfield R, Barrett NL, Harrison LH, Arnold KE, et. al for the Active Bacterial Core Surveillance/Emerging Infections Program Network. Invasive Group A Streptococcal Infection in Older Adults in Long-term Care Facilities and the Community, United States, 1998-2003. Emerg Inf Dis. 2007;13:1852-59.
  • Arnold KE, Schweitzer JL, Wallace B, Salter M, Neeman R, Hlady WG, et al. Tightly clustered outbreak of group A streptococcal disease at a long-term care facility. Infect Control Hosp Epidemiol. 2006;12:1377-84.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2006.
  • Johnson DR , Kaplan EL, VanGheem A, Facklam RR, Beall B. Characterization of group A streptococci (Streptococcus pyogenes): correlation of M-protein and emm-gene type with T-protein agglutination pattern and serum opacity factor. J Med Microbiol. 2006;55:157-64.
  • Persson J, Beall B, Linse S, Lindhal G. Extreme sequence divergence but conserved ligand-binding specificity in Streptococcus pyogenes M protein. PLoS Pathog. 2006;2(5):e47. Epub 2006 May 26.
  • Pletz MW, McGee L, Van Beneden CA, Petit S, Bardsley M, Barlow M, et al. The emergence of fluoroquinolone-resistance in invasive Streptococcus pyogenes isolates due to spontaneous mutation and horizontal gene transfer. Antimicrob Agents Chemother. 2006;50:943-8.
  • Sakota V, Fry AM, Lietman TM, Facklam RR, Li Z, Beall B. Genetically diverse group A streptococci from children in far-western Nepal share high genetic relatedness with isolates from other countries. J Clin Microbiol. 2006;44(6):2160-6.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2005.
  • Dale JB, Penfound T, Chiang EY, Long V, Shulman ST, Beall B. Multivalent group A streptococcal vaccine elicits bactericidal antibodies against variant M subtypes. Clin Diagn Lab Immunol. 2005;12:833-6.
  • Factor SH, Levine OS, Harrison LH, Farley MM, McGeer A, Skoff T, et al. Risk Factors for Pediatric Invasive Group A Streptococcal Disease. Emerg Infect Dis. 2005;11(7):1062-6.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2004.
  • Shulman ST, Tanz RR, Kabat K, Cederlund E, Patel D, Li Z, et al. Group A streptococcal pharyngitis serotype surveillance in North America, 2000-2002. Clin Infect Dis. 2004;39:325-32.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2003.
  • Espinosa LE, Li Z, Rodriguez RS, Facklam R, Beall B. M-protein gene type distribution within group A streptococcal clinical isolates recovered in Mexico during years 1991-2000: Overlap with type distribution within the United States. J Clin Microbiol. 2003;41:373-8.
  • Factor SH, Levine OS, Schwartz B, Harrison LH, Farley MM, McGeer A, et al. Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis. 2003;9(8):970-7.
  • Igwe EI, Shewmaker PL, Facklam RR, Farley MM, Van Beneden C, Beall B. Identification of superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic group C and G streptococci recovered from humans. FEMS Microbiol Lett. 2003;229(2):259-64.
  • Jeng A, Sakota V, Li Z, Datta V, Beall B, Nizet V. Molecular genetic analysis of a group A Streptococcus operon encoding serum opacity factor and a novel fibronectin-binding protein, SfbX. J Bacteriol. 2003;185(4):1208-17.
  • Li Z, Sakota V, Jackson D, Franklin AR, Beall B; Active Bacterial Core Surveillance/Emerging Infections Program Network. Array of M protein gene subtypes in 1064 recent invasive group A streptococcus isolates recovered from the active bacterial core surveillance. J Infect Dis. 2003;188(10):1587-92.
  • Passaro DJ, Smith DS, Hett EC, Reingold AL, Daily P, Van Beneden CA, et al. Invasive Group A Streptococcal Infections in the San Francisco Bay Area, 1989-1999. Epidemiol Infect. 2003;129(3):471-8.
  • Robinson KA, Rothrock G, Phan Q, Sayler B, Stefonek K, Van Beneden C, et al. Active Bacterial Core Surveillance/Emerging Infections Program Network. Risk for severe group A streptococcal disease among patients' household contacts. Emerg Infect Dis. 2003;9(4):443-7.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2002.
  • Chuang I, Van Beneden C, Beall B, Schuchat A and the ABCs/EIP Network. Population-based surveillance for postpartum invasive group A streptococcal infections, 1995-2000. Clin Infect Dis. 2002;35:665-70.
  • Espinosa LE, Li Z, Rodriguez RS, Facklam R, Beall B. M protein gene type distribution within group A streptococcal clinical isolates recovered in Mexico during years 1991-2000: Overlap with type distribution within the United States. J Clin Microbiol. 2002;41:373-8.
  • Facklam RF, Martin DR, Lovgren M, Johnson DR, Efstraiou A, Thompson TA, et al. Extension of the classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm104. Clin Infect Dis. 2002;34:28-38.
  • Hu MC, Walls MA, Stroop S, Reddish M, Beall B, and Dale JB. Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun. 2002;70:2171-77.
  • O'Brien K, Beall B, Barrett NL, Cieslak, Ringold A, Farley MM, et al. Epidemiology of invasive group A streptococcus disease in the United States, 1995-1999. Clin Infect Dis. 2002;35:268-76.
  • The Prevention of Invasive Group A Streptococcal Infections Workshop Participants. Prevention of invasive group A streptococcal disease among household contacts of case-patients and among postpartum and post-surgical patients: Recommendations from the CDC. Clin Infect Dis. 2002;35:950-9.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2001.
  • Stefonek KR, Maerz LL, Nielson MP, Besser RE, Cieslak PR. Group A streptococcal puerperal sepsis preceded by positive surveillance cultures. Obstet Gynecol. 2001;98:846-48.
  • Beall B, Gherardi G, Lovgren M, Forwick B, Facklam R, and Tyrrell G. emm and sof gene sequence variation in relation to serological typing of opacity factor positive group A streptococci. Microbiol. 2000;146:1195-1209.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 2000.
  • Nizet V, Beall B, Bast DJ, Datta V, Kilburn L, Low DE, et al. Genetic locus for streptolysin S production by group A streptococcus. Infect Immun. 2000;68(7):4245-54.

top of page

1995-1999:

  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 1999.
  • Facklam R, Beall B, Efstratiou A, Fischetti V, Johnson D, Kaplan E, et al. Demonstration of emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis. 1999;5:247-53.
  • Hoe NP, Nakashima K, Lukomski S, Grigsby D, Liu M, Kordari P, et al. Rapid selection of structural variants of group A streptococcus complement-inhibiting protein sustains and enlarges serotype M1 epidemic waves. Nat Med. 1999;5:924-9.
  • York MK, Gibbs L, Perdreau-Remington F, Brooks GF. Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of Northern California. J Clin Microbiol. 1999;37(6):1727-31.
  • Beall B, Facklam R, Elliott JA, Franklin AR, Hoenes T, Jackson D, et al. Streptococcal emm types associated with T agglutination patterns and the use of conserved emm gene restriction fragment patterns for sub-typing group A streptococci. J Med Microbiol. 1998;47:893-8.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 1998.
  • The Working Group on Prevention of Invasive Group A Streptococcal Infections. Prevention of invasive group A streptococcal disease among household contacts of case-patients. JAMA .1998;279:1206-10.
  • Zurawski CA, Bardsley M, Beall B, Elliott JA, Facklam RR, Schwartz B, et al. Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment. Clin Infect Dis. 1998;27:150-7.
  • Beall B, Facklam R, Hoenes T, Schwartz B. A survey of emm gene sequences from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995. J Clin Microbiol. 1997;35:1231-5.
  • Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Group A Streptococcus, 1997.
  • Fiorentino TR,Beall B, Mshar P, Bessen DE. A genetic-based evaluation of principal tissue reservoir for group A streptococci isolated from normally sterile sites. J Infect Dis. 1997;176:177-82.
  • Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol. 1996;34:953-58.

top of page

Images and logos on this website which are trademarked/copyrighted or used with permission of the trademark/copyright or logo holder are not in the public domain. These images and logos have been licensed for or used with permission in the materials provided on this website. The materials in the form presented on this website may be used without seeking further permission. Any other use of trademarked/copyrighted images or logos requires permission from the trademark/copyright holder...more

External Web Site Policy This graphic notice means that you are leaving an HHS Web site. For more information, please see the Exit Notification and Disclaimer policy.

 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
    Contact CDC-INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #